| The presence of depression at 2-year follow up | |
---|---|---|
 | Univariate | Multivariate 1 |
 | OR (95% CI) | OR (95% CI) |
Socio-demographics | Â | Â |
- Age at baseline, in years | 1.01 (0.98 – 1.04) |  |
- Female gender | 0.97 (0.59 – 1.58) |  |
- Education, in years | 0.99 (0.92 – 1.05) |  |
- No partner | 1.34 (0.84 – 2.13) |  |
- Sampling site | Â | Â |
 - Amsterdam | Ref group | Ref group |
 - Leiden | 1.21 (0.65 – 2.25) | 1.63 (0.81-3.29) |
 - Groningen | 0.78 (0.38 – 1.59) | 0.95 (0.42-2.11) |
 - Apeldoorn/Zutphen | 0.45 (0.20 – 1.04) | 0.56 (0.21-1.53) |
 - Nijmegen | 0.73 (0.33 – 1.63) | 0.81 (0.32-2.06) |
Clinical characteristics at baseline | Â | Â |
- First episode MDD | 0.98 (0.62 – 1.56) |  |
- Dysthymia | 2.03 (1.19 – 3.49) | 1.30 (0.71-2.37) |
- Onset of depression, in years | 0.98 (0.97 – 0.995) | 0.99 (0.98-1.00) |
- Comorbid anxiety disorder | 1.45 (0.90 – 2.35) |  |
- Severity depression symptoms | 1.06 (1.04 – 1.08) | 1.05 (1.03-1.07) |
Sampling frame | Â | Â |
- Primary care | Ref group | Ref group |
- Ambulant mental health care | 0.63 (0.32 – 1.24) | 0.57 (0.26-1.21) |
- Clinical mental health care | 0.36 (0.13 – 0.96) | 0.43 (0.13-1.42) |
- Use anti depressive medication | 0.88 (0.53 – 1.47) |  |
- Use of benzodiazepines | 1.05 (0.83 – 1.34) |  |
Comorbidity at baseline | Â | Â |
- Number of chronic diseases | 1.37 (1.16 – 1.63) | 1.21 (1.01-1.46) |
- MMSE | 0.91 (0.80 – 1.04) |  |